Time Finance plc (LON:TIME), the independent specialist finance provider, has announced that it has delivered its first Asset Based Lending (ABL) facility to aid the expansion of a growing steel..
Yü Group plc (LON:YU) is the topic of conversation when Co Fund Manager Gervais Williams of Premier Miton Investors caught up with DirectorsTalk for an exclusive interview to discuss the..
Inchcape plc (LON:INCH), the leading global automotive distributor, has today announced that Adrian Lewis has been appointed as Group Chief Financial Officer (CFO) and Executive Director of Inchcape plc from..
Vistry Group PLC (LON:VTY) has announced its Partnerships division, Countryside Partnerships, has been selected as preferred partner for a 50/50 joint venture with Goram Homes, Bristol City Council’s housing company,..
Intertek Group plc (LON:ITRK), a leading Total Quality Assurance provider to industries worldwide, has released its May Trading Update for the period from 1 January to 30 April 2023. All..
Kingfisher plc (LON:KGF) has provided its Q1 23/24 sales. Key points · First quarter sales of £3.3bn; total sales +0.8% (reported) and -2.0% (constant currency) · LFL -3.3% including a -0.5% calendar..
XP Factory plc (LON:XPF) Chief Executive Officer Richard Harpham joins DirectorsTalk Interviews to discuss final results for the year ended 31 December 2022. Richard talks us through the result highlights,..
Zotefoams plc (LON:ZTF), a world leader in cellular materials technology, has provided a trading update for the four months ended 30 April 2023, ahead of its Annual General Meeting to..
4GLOBAL plc (LON:4GBL), a UK-based data, services and software company, has announced the signing of a strategic partnership agreement to exploit a multi-million pound opportunity with the fitness equipment and..
Active Energy Group plc (LON:AEG), the international biomass based renewable energy business, has announced that Player Design Inc has informed the Company that it has received the relevant permit for the..
Poolbeg Pharma plc (LON:POLB), a leading biopharmaceutical company focusing on infectious and prevalent diseases with a high unmet medical need, has announced the appointment of Brendan Buckley as an Independent Non-Executive Director of..
